The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...

Upstream's breeding technologies, which protect plants from yield-threatening diseases, have already delivered strong results ...

Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary of global life sciences titan Bayer AG. Financial terms of the deal with ...

The Southeast Regional Fruit & Vegetable Conference takes place in Savannah, GA, Jan. 9-11. This event is for fruit and vegetable growers and others interested in learning about produce safety, the ...

In biochemistry lingo, an “active site” refers to a spot on an enzyme that can produce a chemical reaction when a molecule binds to it. In economic development lingo, an “active site” can be a land ...

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences. North Carolina is home to 840 life ...

Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA ...

The life sciences version of March Madness 2024 has just tipped off across North Carolina. The North Carolina Biotechnology Center, celebrating its 40th anniversary this year, launched the biannual, ...

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health has announced new small business funding opportunities through the Small Business Innovation ...

In his ophthalmology practice, Surgical Eye Care in Wilmington, Alan Brown, M.D., is “always bumping up against things that could be done better.” As he performs cataract and refractive surgeries, ...

Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form a North ...